United States

Edwards Lifesciences Corporation EW

NYSE Health technology USD

Edwards Lifesciences Corporation is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. The company specializes in developing and manufacturing advanced medical devices, primarily focusing on heart valve therapies and hemodynamic monitoring systems. It serves healthcare providers, hospitals, and patients worldwide, with a significant presence in the United States, Europe, Japan, and other international markets. Edwards Lifesciences operates through a business model centered on research and development, clinical trials, regulatory approvals, and global commercialization of its medical technologies. The company invests heavily in innovation to address unmet clinical needs in cardiovascular disease, driving growth through new product introductions and expansion into emerging markets.

Current Price USD 83.28
Daily Change -1.23%
Market Cap USD 48.33 B
Shares Outstanding 580.3 M
Forecast

LSTM Forecast

Forecast model is not trained yet for this market.

Next 5 Trading Days

Train and backfill the LSTM forecast to surface a directional view here.

Chart